SUBSEQUENT PURCHASE AND SALE AGREEMENT between ARPI LLC, as Seller, and PDL BIOPHARMA, INC., as Purchaser Dated as of September 18, 2015Subsequent Purchase and Sale Agreement • November 3rd, 2015 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 3rd, 2015 Company Industry JurisdictionThis SUBSEQUENT PURCHASE AND SALE AGREEMENT (this “SPSA”), dated as of September 18, 2015, is entered into between ARPI LLC, a Delaware limited liability company (the “Seller”), and PDL BioPharma, Inc., a Delaware corporation (the “Purchaser”).